Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., ...

CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Hence, it is the balance between pro- and anti-inflammatory cytokines that dictates outcome in lung host defense. Schematic depicting the role of cytokines and lung cells in innate immunity ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

Aclaris Therapeutics (ACRS) announced the availability of a new publication describing properties of Aclaris Therapeutics’ ATI-2138, a novel ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

Preterm birth (PTB) continues to pose a challenge in neonatal medicine, and it is the major cause of perinatal morbidity and ...

Coya Therapeutics' Phase 2 study shows monthly LD IL-2 improves cognitive scores and reduces inflammation in Alzheimer's ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to ...

Excess sugar does more than just cause weight gain—it fuels chronic inflammation, disrupts gut health, and spikes insulin ...